Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELAR: Short DAPT with Ticagrelor in Chronic Coronary Artery Disease
NCT07080684Phase 4Not yet recruiting
- Sponsor
- University of Messina
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ticagrelor in Chronic Coronary Syndrome (CCS), sponsored by University of Messina. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ticagrelor
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT07080684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080684.